AAMI holder plans Rule 144 sale of 28,753 shares

AAMI has a shareholder filing a Rule 144 notice to sell 28,753 shares of common stock through Fidelity Brokerage Services LLC on the NYSE.

Rhea-AI Filing Summary

AAMI has a shareholder filing a Rule 144 notice to sell 28,753 shares of common stock through Fidelity Brokerage Services LLC on the NYSE. The aggregate market value of the planned sale is $1,474,741.37. Shares outstanding are listed as 35,709,120, providing context for the transaction size.

The shares come from stock awards granted by the issuer between 2018 and 2024 as compensation, with multiple award dates and amounts detailed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the AAMI Rule 144 filing disclose?

The filing discloses that a shareholder plans to sell 28,753 AAMI common shares under Rule 144. The planned sale has an aggregate market value of $1,474,741.37 and will be executed through Fidelity Brokerage Services LLC on the NYSE, subject to Rule 144 conditions.

How many AAMI shares are planned for sale under this Rule 144 notice?

The shareholder plans to sell 28,753 AAMI common shares. The filing lists these shares with an aggregate market value of $1,474,741.37, to be sold on the NYSE via Fidelity Brokerage Services LLC, with an approximate sale date of February 11, 2026.

What is the aggregate market value of the AAMI shares to be sold?

The aggregate market value of the 28,753 AAMI common shares planned for sale is $1,474,741.37. This figure reflects the total market value of the proposed Rule 144 transaction as disclosed in the filing’s securities information table.

How many AAMI shares are outstanding according to the Rule 144 filing?

The filing states that 35,709,120 AAMI common shares are outstanding. This number is included in the securities information table and provides context for the 28,753 shares planned for sale under Rule 144 through Fidelity on the NYSE.

When is the approximate sale date for the AAMI Rule 144 shares?

The approximate sale date for the 28,753 AAMI common shares is listed as February 11, 2026. The filing shows these shares will be sold on the NYSE through Fidelity Brokerage Services LLC, subject to Rule 144 requirements and market conditions at that time.

How were the AAMI shares being sold under Rule 144 originally acquired?

The shares were originally acquired as stock awards from the issuer between 2018 and 2024. The filing lists multiple award dates, amounts, and identifies the nature of payment as compensation, indicating the seller received these AAMI shares as part of their compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/11/2026 - 09:40 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001668247
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Acadian Asset Management Inc.
SEC File Number	001-38979
Address of Issuer	200 STATE STREET SUITE 601A BOSTON MASSACHUSETTS 02109
Phone	6173697300
Name of Person for Whose Account the Securities are To Be Sold	Chersi Robert J
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Spouse

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	28753	1474741.37	35709120	02/11/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/18/2018	Stock Award	Issuer			3000	05/18/2018	Compensation
Common	02/15/2018	Stock Award	Issuer			2204	02/15/2018	Compensation
Common	01/23/2021	Stock Award	Issuer			10215	01/23/2021	Compensation
Common	06/07/2022	Stock Award	Issuer			4193	06/07/2022	Compensation
Common	06/07/2023	Stock Award	Issuer			4762	06/08/2023	Compensation
Common	06/07/2024	Stock Award	Issuer			4379	06/07/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	shares sold out of the ROBERT J CHERSI 2012 FAMILY TRUST by wifes name Rosemary Chersi
Date of Notice	02/11/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Gardea as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Chersi Robert J.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)